Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2023-10-19 | 2023-11-30 | 207506 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Resolved | 2023-10-19 | 2023-11-09 | 207509 |
TEVA-NITROFURANTOIN | 50MG | CAPSULE | Resolved | 2023-10-19 | 2023-11-30 | 207515 |
TEVA-METFORMIN | 500MG | TABLET | Resolved | 2023-10-19 | 2023-12-07 | 207521 |
TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2023-10-19 | 2023-12-07 | 207524 |
TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2023-10-19 | 2023-12-14 | 207527 |
TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-10-19 | 2024-05-03 | 207530 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-10-19 | 2023-11-30 | 207533 |
TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2023-10-19 | 2024-02-22 | 207536 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-10-19 | 2023-12-07 | 207539 |
TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-10-19 | 2024-04-11 | 207548 |
TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-10-19 | 2024-03-21 | 207551 |
TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2023-10-26 | 2023-11-09 | 208251 |
TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2023-10-26 | 2023-11-23 | 208254 |
TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-10-26 | 2023-11-03 | 208257 |
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2023-10-26 | 2024-01-11 | 208260 |
TEVA-FLUVOXAMINE | 100MG | TABLET | Resolved | 2023-11-03 | 2024-05-09 | 209108 |
TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2023-11-03 | 2024-04-25 | 209111 |
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2023-11-03 | 2023-12-14 | 209116 |
TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2023-11-03 | 2023-12-14 | 209119 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |